{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:50Z","timestamp":1790352530025,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s11427-025-3167-7","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:26:07Z","timestamp":1776932767000},"page":"2328-2341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artemisinin derivative SM934 targets \u03b1-enolase to inhibit PEP-mediated TAK1 stabilization and inflammation"],"prefix":"10.1007","volume":"69","author":[{"given":"Jun","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miya","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qielan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"3167_CR1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41591-024-03165-6","volume":"30","author":"TE Adolph","year":"2024","unstructured":"Adolph, T.E., and Tilg, H. (2024). Western diets and chronic diseases. Nat Med 30, 2133\u20132147.","journal-title":"Nat Med"},{"key":"3167_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker, R.G., Hayden, M.S., and Ghosh, S. (2011). NF-\u03baB, inflammation, and metabolic disease. Cell Metab 13, 11\u201322.","journal-title":"Cell Metab"},{"key":"3167_CR3","doi-asserted-by":"publisher","first-page":"108810","DOI":"10.1016\/j.pharmthera.2025.108810","volume":"267","author":"NS Benedik","year":"2025","unstructured":"Benedik, N.S., Proj, M., Steinebach, C., Sova, M., and Sosi\u010d, I. (2025). Targeting TAK1: evolution of inhibitors, challenges, and future directions. Pharmacol Ther 267, 108810.","journal-title":"Pharmacol Ther"},{"key":"3167_CR4","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","volume":"9","author":"JL Bridgford","year":"2018","unstructured":"Bridgford, J.L., Xie, S.C., Cobbold, S.A., Pasaje, C.F.A., Herrmann, S., Yang, T., Gillett, D.L., Dick, L.R., Ralph, S.A., Dogovski, C., et al. (2018). Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat Commun 9, 3801.","journal-title":"Nat Commun"},{"key":"3167_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.copbio.2019.12.008","volume":"63","author":"EC Britt","year":"2020","unstructured":"Britt, E.C., John, S.V., Locasale, J.W., and Fan, J. (2020). Metabolic regulation of epigenetic remodeling in immune cells. Curr Opin Biotechnol 63, 111\u2013117.","journal-title":"Curr Opin Biotechnol"},{"key":"3167_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck, M.D., Sowell, R.T., Kaech, S.M., and Pearce, E.L. (2017). Metabolic instruction of immunity. Cell 169, 570\u2013586.","journal-title":"Cell"},{"key":"3167_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","volume":"43","author":"D Capece","year":"2022","unstructured":"Capece, D., Verzella, D., Flati, I., Arboretto, P., Cornice, J., and Franzoso, G. (2022). NF-\u03baB: blending metabolism, immunity, and inflammation. Trends Immunol 43, 757\u2013775.","journal-title":"Trends Immunol"},{"key":"3167_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2010.02.043","volume":"140","author":"CA Dinarello","year":"2010","unstructured":"Dinarello, C.A. (2010). Anti-inflammatory agents: present and future. Cell 140, 935\u2013950.","journal-title":"Cell"},{"key":"3167_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.apsb.2020.09.001","volume":"11","author":"D Dolivo","year":"2021","unstructured":"Dolivo, D., Weathers, P., and Dominko, T. (2021). Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics. Acta Pharm Sin B 11, 322\u2013339.","journal-title":"Acta Pharm Sin B"},{"key":"3167_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bcp.2017.03.019","volume":"139","author":"T Efferth","year":"2017","unstructured":"Efferth, T. (2017a). Cancer combination therapies with artemisinin-type drugs. Biochem Pharmacol 139, 56\u201370.","journal-title":"Biochem Pharmacol"},{"key":"3167_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","volume":"46","author":"T Efferth","year":"2017","unstructured":"Efferth, T. (2017b). From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol 46, 65\u201383.","journal-title":"Semin Cancer Biol"},{"key":"3167_CR12","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/med.21842","volume":"41","author":"T Efferth","year":"2021","unstructured":"Efferth, T., and Oesch, F. (2021). The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases. Med Res Rev 41, 3023\u20133061.","journal-title":"Med Res Rev"},{"key":"3167_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav, E., Nowarski, R., Thaiss, C.A., Hu, B., Jin, C., and Flavell, R.A. (2013). Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 13, 759\u2013771.","journal-title":"Nat Rev Cancer"},{"key":"3167_CR14","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.cellsig.2012.02.017","volume":"24","author":"Y Fan","year":"2012","unstructured":"Fan, Y., Shi, Y., Liu, S., Mao, R., An, L., Zhao, Y., Zhang, H., Zhang, F., Xu, G., Qin, J., et al. (2012). Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNF\u03b1-induced NF-\u03baB activation via mediating TAK1 degradation. Cell Signal 24, 1381\u20131389.","journal-title":"Cell Signal"},{"key":"3167_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., and Santoro, A. (2018). Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14, 576\u2013590.","journal-title":"Nat Rev Endocrinol"},{"key":"3167_CR16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/med.22001","volume":"44","author":"X Gao","year":"2024","unstructured":"Gao, X., Lin, X., Wang, Q., and Chen, J. (2024). Artemisinins: promising drug candidates for the treatment of autoimmune diseases. Med Res Rev 44, 867\u2013891.","journal-title":"Med Res Rev"},{"key":"3167_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/metabo10110426","volume":"10","author":"WH Godfrey","year":"2020","unstructured":"Godfrey, W.H., and Kornberg, M.D. (2020). The role of metabolic enzymes in the regulation of inflammation. Metabolites 10, 426.","journal-title":"Metabolites"},{"key":"3167_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen, M.F., Samson, N., Keller, A., Schwabenland, M., Liu, C., Gl\u00fcck, S., Thacker, V. V., Favre, L., Mangeat, B., Kroese, L.J., et al. (2023). cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374\u2013380.","journal-title":"Nature"},{"key":"3167_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., and Zhang, J. (2024a). NF-\u03baB in biology and targeted therapy: new insights and translational implications. Sig Transduct Target Ther 9, 53.","journal-title":"Sig Transduct Target Ther"},{"key":"3167_CR20","doi-asserted-by":"publisher","first-page":"109687","DOI":"10.1016\/j.jnutbio.2024.109687","volume":"131","author":"Y Guo","year":"2024","unstructured":"Guo, Y., Chen, Y., Wang, D., Liu, G., Chen, Y., Peng, C., Cao, T., Liu, Y., Hu, X., Xu, X., et al. (2024b). Artemisinin and its derivatives modulate glucose homeostasis and gut microbiota remodeling in a nutritional context. J Nutral Biochem 131, 109687.","journal-title":"J Nutral Biochem"},{"key":"3167_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.freeradbiomed.2024.05.009","volume":"221","author":"Y Hirata","year":"2024","unstructured":"Hirata, Y., Nakata, Y., Komatsu, H., Kudoh, Y., Takahashi, M., Taguchi, S., Noguchi, T., and Matsuzawa, A. (2024). Roquin-2 promotes oxidative stress-induced cell death by ubiquitination-dependent degradation of TAK1. Free Radical Biol Med 221, 31\u201339.","journal-title":"Free Radical Biol Med"},{"key":"3167_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/ijms18010205","volume":"18","author":"Y Hirata","year":"2017","unstructured":"Hirata, Y., Takahashi, M., Morishita, T., Noguchi, T., and Matsuzawa, A. (2017). Post-translational modifications of the TAK1-TAB complex. Int J Mol Sci 18, 205.","journal-title":"Int J Mol Sci"},{"key":"3167_CR23","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","volume":"162","author":"PC Ho","year":"2015","unstructured":"Ho, P.C., Bihuniak, J.D., Macintyre, A.N., Staron, M., Liu, X., Amezquita, R., Tsui, Y. C., Cui, G., Micevic, G., Perales, J.C., et al. (2015). Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell 162, 1217\u20131228.","journal-title":"Cell"},{"key":"3167_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","volume":"142","author":"WE Ho","year":"2014","unstructured":"Ho, W.E., Peh, H.Y., Chan, T.K., and Wong, W.S.F. (2014). Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther 142, 126\u2013139.","journal-title":"Pharmacol Ther"},{"key":"3167_CR25","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.intimp.2009.09.003","volume":"9","author":"LF Hou","year":"2009","unstructured":"Hou, L.F., He, S.J., Wang, J.X., Yang, Y., Zhu, F.H., Zhou, Y., He, P.L., Zhang, Y., Yang, Y.F., Li, Y., et al. (2009). SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo. Int Immunopharmacol 9, 1509\u20131517.","journal-title":"Int Immunopharmacol"},{"key":"3167_CR26","doi-asserted-by":"publisher","first-page":"112205","DOI":"10.1016\/j.celrep.2023.112205","volume":"42","author":"TY Huang","year":"2023","unstructured":"Huang, T.Y., Hirota, M., Sasaki, D., Kalra, R.S., Chien, H.C., Tamai, M., Sarkar, S., Mi, Y., Miyagi, M., Seto, Y., et al. (2023). Phosphoenolpyruvate regulates the Th17 transcriptional program and inhibits autoimmunity. Cell Rep 42, 112205.","journal-title":"Cell Rep"},{"key":"3167_CR27","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1073\/pnas.1600459113","volume":"113","author":"HM Ismail","year":"2016","unstructured":"Ismail, H.M., Barton, V., Phanchana, M., Charoensutthivarakul, S., Wong, M.H.L., Hemingway, J., Biagini, G.A., O\u2019Neill, P.M., and Ward, S.A. (2016). Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7. Proc Natl Acad Sci USA 113, 2080\u20132085.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3167_CR28","doi-asserted-by":"publisher","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","volume":"2","author":"A Isra\u00ebl","year":"2010","unstructured":"Isra\u00ebl, A. (2010). The IKK complex, a central regulator of NF-\u03baB activation. Cold Spring Harb Perspect Biol 2, a000158.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3167_CR29","doi-asserted-by":"publisher","first-page":"11267","DOI":"10.1038\/ncomms11267","volume":"7","author":"YX Ji","year":"2016","unstructured":"Ji, Y.X., Zhang, P., Zhang, X.J., Zhao, Y.C., Deng, K.Q., Jiang, X., Wang, P.X., Huang, Z., and Li, H. (2016). The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling. Nat Commun 7, 11267.","journal-title":"Nat Commun"},{"key":"3167_CR30","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jaci.2020.07.027","volume":"146","author":"M Kracht","year":"2020","unstructured":"Kracht, M., M\u00fcller-Ladner, U., and Schmitz, M.L. (2020). Mutual regulation of metabolic processes and proinflammatory NF-\u03baB signaling. J Allergy Clin Immunol 146, 694\u2013705.","journal-title":"J Allergy Clin Immunol"},{"key":"3167_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cell.2016.11.010","volume":"168","author":"J Li","year":"2017","unstructured":"Li, J., Casteels, T., Frogne, T., Ingvorsen, C., Honor\u00e9, C., Courtney, M., Huber, K.V.M., Schmitner, N., Kimmel, R.A., Romanov, R.A., et al. (2017). Artemisinins target GABAA receptor signaling and impair \u03b1 cell identity. Cell 168, 86\u2013100.e15.","journal-title":"Cell"},{"key":"3167_CR32","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.2147\/OTT.S297785","volume":"14","author":"Q Li","year":"2021","unstructured":"Li, Q., Ma, Q., Cheng, J., Zhou, X., Pu, W., Zhong, X., and Guo, X. (2021). Dihydroartemisinin as a sensitizing agent in cancer therapies. Onco Targets Ther Volume 14, 2563\u20132573.","journal-title":"Onco Targets Ther Volume"},{"key":"3167_CR33","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1007\/s11427-020-1840-1","volume":"64","author":"Z Lin","year":"2021","unstructured":"Lin, Z., Liu, Y., Chen, L., Cao, S., Huang, Y., Yang, X., Zhu, F., Tang, W., He, S., and Zuo, J. (2021). Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets. Sci China Life Sci 64, 1702\u20131719.","journal-title":"Sci China Life Sci"},{"key":"3167_CR34","doi-asserted-by":"publisher","first-page":"eadk5382","DOI":"10.1126\/science.adk5382","volume":"384","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Jiang, J., Du, S., Mu, L., Fan, J., Hu, J., Ye, Y., Ding, M., Zhou, W., Yu, Q., et al. (2024). Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction. Science 384, eadk5382.","journal-title":"Science"},{"key":"3167_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41584-021-00648-5","volume":"17","author":"RB Lochhead","year":"2021","unstructured":"Lochhead, R.B., Strle, K., Arvikar, S.L., Weis, J.J., and Steere, A.C. (2021). Lyme arthritis: linking infection, inflammation and autoimmunity. Nat Rev Rheumatol 17, 449\u2013461.","journal-title":"Nat Rev Rheumatol"},{"key":"3167_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1074\/jbc.R115.693903","volume":"291","author":"RM Loftus","year":"2016","unstructured":"Loftus, R.M., and Finlay, D.K. (2016). Immunometabolism: cellular metabolism turns immune regulator. J Biol Chem 291, 1\u201310.","journal-title":"J Biol Chem"},{"key":"3167_CR37","first-page":"628","volume":"42","author":"C Ma","year":"2019","unstructured":"Ma, C., Zu, X., Liu, K., Bode, A.M., Dong, Z., Liu, Z., and Kim, D.J. (2019). Knockdown of pyruvate kinase m inhibits cell growth and migration by reducing NF-\u03baB activity in triple-negative breast cancer cells. Mol Cells 42, 628\u2013636.","journal-title":"Mol Cells"},{"key":"3167_CR38","doi-asserted-by":"publisher","first-page":"107198","DOI":"10.1016\/j.micpath.2024.107198","volume":"199","author":"N Ma","year":"2025","unstructured":"Ma, N., Wang, L., Meng, M., Wang, Y., Huo, R., Chang, G., and Shen, X. (2025). D-sodium lactate promotes the activation of NF-\u03baB signaling pathway induced by lipopolysaccharide via histone lactylation in bovine mammary epithelial cells. Microb Pathog 199, 107198.","journal-title":"Microb Pathog"},{"key":"3167_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","volume":"520","author":"A Mbengue","year":"2015","unstructured":"Mbengue, A., Bhattacharjee, S., Pandharkar, T., Liu, H., Estiu, G., Stahelin, R.V., Rizk, S.S., Njimoh, D.L., Ryan, Y., Chotivanich, K., et al. (2015). A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature 520, 683\u2013687.","journal-title":"Nature"},{"key":"3167_CR40","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/s41388-019-1088-8","volume":"39","author":"H Mukhopadhyay","year":"2020","unstructured":"Mukhopadhyay, H., and Lee, N.Y. (2020). Multifaceted roles of TAK1 signaling in cancer. Oncogene 39, 1402\u20131413.","journal-title":"Oncogene"},{"key":"3167_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41577-021-00580-5","volume":"21","author":"AJ Murphy","year":"2021","unstructured":"Murphy, A.J., and Febbraio, M.A. (2021). Immune-based therapies in cardiovascular and metabolic diseases: past, present and future. Nat Rev Immunol 21, 669\u2013679.","journal-title":"Nat Rev Immunol"},{"key":"3167_CR42","doi-asserted-by":"publisher","first-page":"30106","DOI":"10.1038\/srep30106","volume":"6","author":"N Nagasundaram","year":"2016","unstructured":"Nagasundaram, N., George Priya Doss, C, Chakraborty, C., Karthick, V., Thirumal Kumar, D., Balaji, V., Siva, R., Lu, A., Ge, Z., and Zhu, H. (2016). Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials: an integrated computational approach. Sci Rep 6, 30106.","journal-title":"Sci Rep"},{"key":"3167_CR43","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.immuni.2022.10.021","volume":"55","author":"NA Schmacke","year":"2022","unstructured":"Schmacke, N.A., O\u2019Duill, F., Gaidt, M.M., Szymanska, I., Kamper, J.M., Schmid-Burgk, J.L., M\u00e4dler, S.C., Mackens-Kiani, T., Kozaki, T., Chauhan, D., et al. (2022). IKK\u03b2 primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network. Immunity 55, 2271\u20132284.e7.","journal-title":"Immunity"},{"key":"3167_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejphar.2011.06.044","volume":"668","author":"L Shakir","year":"2011","unstructured":"Shakir, L., Hussain, M., Javeed, A., Ashraf, M., and Riaz, A. (2011). Artemisinins and immune system. Eur J Pharmacol 668, 6\u201314.","journal-title":"Eur J Pharmacol"},{"key":"3167_CR45","doi-asserted-by":"publisher","first-page":"849014","DOI":"10.3389\/fphar.2022.849014","volume":"13","author":"M Shao","year":"2022","unstructured":"Shao, M., Yan, Y., Zhu, F., Yang, X., Qi, Q., Yang, F., Hao, T., Lin, Z., He, P., Zhou, Y., et al. (2022). Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis. Front Pharmacol 13, 849014.","journal-title":"Front Pharmacol"},{"key":"3167_CR46","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1038\/s41401-022-00978-4","volume":"43","author":"X Tong","year":"2022","unstructured":"Tong, X., Chen, L., He, S., and Zuo, J. (2022). Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms. Acta Pharmacol Sin 43, 3055\u20133061.","journal-title":"Acta Pharmacol Sin"},{"key":"3167_CR47","doi-asserted-by":"publisher","first-page":"114815","DOI":"10.1016\/j.celrep.2024.114815","volume":"43","author":"P Wang","year":"2024","unstructured":"Wang, P., Chen, L.L., Xiong, Y., and Ye, D. (2024). Metabolite regulation of epigenetics in cancer. Cell Rep 43, 114815.","journal-title":"Cell Rep"},{"key":"3167_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.molcel.2019.07.007","volume":"76","author":"X Wang","year":"2019","unstructured":"Wang, X., Liu, R., Qu, X., Yu, H., Chu, H., Zhang, Y., Zhu, W., Wu, X., Gao, H., Tao, B., et al. (2019). \u03b1-ketoglutarate-activated NF-\u03baB signaling promotes compensatory glucose uptake and brain tumor development. Mol Cell 76, 148\u2013162.e7.","journal-title":"Mol Cell"},{"key":"3167_CR49","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature08247","volume":"461","author":"ZP Xia","year":"2009","unstructured":"Xia, Z.P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., and Chen, Z.J. (2009). Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114\u2013119.","journal-title":"Nature"},{"key":"3167_CR50","doi-asserted-by":"publisher","first-page":"608976","DOI":"10.3389\/fimmu.2020.608976","volume":"11","author":"YR Xu","year":"2021","unstructured":"Xu, Y.R., and Lei, C.Q. (2021). TAK1-TABs complex: a central signalosome in inflammatory responses. Front Immunol 11, 608976.","journal-title":"Front Immunol"},{"key":"3167_CR51","doi-asserted-by":"publisher","first-page":"24497","DOI":"10.1074\/jbc.M802825200","volume":"283","author":"Y Yu","year":"2008","unstructured":"Yu, Y., Ge, N., Xie, M., Sun, W., Burlingame, S., Pass, A.K., Nuchtern, J.G., Zhang, D., Fu, S., Schneider, M.D., et al. (2008). Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin (IL)-1-mediated optimal NF\u03baB and AP-1 activation as well as IL-6 gene expression. J Biol Chem 283, 24497\u201324505.","journal-title":"J Biol Chem"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-3167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-025-3167-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-3167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:03:42Z","timestamp":1781827422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-025-3167-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3167"],"URL":"https:\/\/doi.org\/10.1007\/s11427-025-3167-7","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. All animal procedures were approved by the Institutional Animal Care and Use Committee of the University of Science and Technology of China (Approval No. USTCACUC28110124045) and the Animal Ethics Committee of Institute of Health and Medicine, Hefei Comprehensive National Science Center (Approval No. YXLL2023001), and experiments were performed in accordance with the approved guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}